4D Molecular Therapeutics develops genetic medicines for eye diseases and cystic fibrosis, based in Emeryville, California. It last closed at $10.23 on Nov 20, down 4.57% on the day. The next earnings report for FDMT is expected around Wed, Mar 17, 2027, after the close. For the quarter ended Sep 2026, FDMT reported EPS of -$1.08 on revenue of $4.1M, with revenue up 4505.6% from a year ago. Over its last 8 reports the stock moved an average of 3.9% the session after earnings. Over the last 12 months FDMT insiders bought $0 of stock on the open market and sold $5.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is FDMT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold FDMT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on FDMTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
FDMT · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 15% below its 20 day and 25% below its 50 day average. It is 9% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot S1 at $9.91, and the nearest resistance the Pivot at $10.43.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 8.9%/day
Key levels
$16.9352 week high+65.5%
$12.8050 day average+25.1%
$12.70100 day average+24.1%
$11.7720 day average+15.1%
$11.12200 day average+8.7%
$10.74Pivot R1+5.0%
$10.45Swing high (Jun 4)+2.2%
$10.43Pivot+2.0%
$10.23Last close
$9.91Pivot S1−3.1%
$9.39Swing low (Jul 29)−8.2%
$6.9652 week low−32.0%
Indicators
RSI (14)
37.50
Weak, oversold below 30
Neutral
MACD
-0.53
Below its signal line
Bearish
Stochastic
8.4
Near the bottom of its range
Oversold
ADX (14)
15.4
No clear trend
Williams %R
-96.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-147.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−16.5%
Change over 10 sessions
Bearish
ATR (14)
$0.91
Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 19.5%/day
Key levels
$16.9352 week high+65.5%
$12.8050 day average+25.1%
$12.70100 day average+24.1%
$11.7720 day average+15.1%
$11.12200 day average+8.7%
$10.74Pivot R1+5.0%
$10.45Swing high (Jun 4)+2.2%
$10.43Pivot+2.0%
$10.23Last close
$9.91Pivot S1−3.1%
$9.39Swing low (Jul 29)−8.2%
$6.9652 week low−32.0%
Indicators
RSI (14)
43.94
Middle of its range
Neutral
MACD
0.30
Below its signal line
Bearish
Stochastic
21.3
Middle of its range
Neutral
ADX (14)
27.5
Trending up
Williams %R
-98.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-82.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−22.3%
Change over 10 sessions
Bearish
ATR (14)
$2.00
Typical daily range, 19.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for FDMT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how FDMT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow FDMT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for FDMTHow many large options trades hit FDMT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in FDMT in the last 90 days.
From SEC Form 4 filings by FDMT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FDMT is in one of them and how their past FDMT trades turned out.
4D Molecular Therapeutics is a biotechnology company that develops genetic medicines. Its product candidates use modified adeno-associated virus vectors, which are designed to carry therapeutic genes to target tissues. Its lead candidate is aimed at wet age-related macular degeneration and diabetic macular edema, two eye diseases, and is designed to be given by injection in a doctor's office. The company is also developing a treatment for lung disease in people with cystic fibrosis. It is based in Emeryville, California, and its intended customers are patients, eye and lung specialists, and healthcare payers.